Clinical Trials Browser

Phase 2 × Lymphoma, Non-Hodgkin × epratuzumab × Clear all

NCT00044902 2007-12-28

Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)

Phase 2 Completed

Lymphoma, Non-Hodgkin